|
| Main Title : Update on Diabetes Mellitus |
|
| Plenary Lecture I |
(Fri. 9, 09:50~10:50, Room A)
|
|
 |
Insulin resistance and beta cell failure in type 2 diabetes |
Domenico Accili
(Columbia University, USA)
 |
|
|
| Plenary Lecture II |
(Sat. 10, 10:00~11:00, Room A)
|
|
 |
The TORC family of CREB coactivators: Regulators of energy balance |
Marc Montminy
(The Salk Institute, USA)
|
|
|
| Main Symposia |
|
| I. Beta Cell and Diabetes Mellitus (English) | (Fri. 9, 11:00~13:00, Room A)
|
|
 |
1. Regulation of insulin granule dynamics |
Susumu Seino
(Kobe University,Japan)
|
 |
 |
2. Pancreatic islet imaging: What do we want to know and how do we measure it? |
Alvin C. Powers
(Vanderbilt University, USA)
|
|
 |
3. Membrane trafficking during insulin secretion |
John C. Hutton
(Barbara Davis Center, USA)
|
|
 |
4. Type 1 DM suppression and beta-cell proliferation in novel
leptin receptor mutation NOD mice |
Chul-Ho Lee
(Korean Research Institute of Bioscience & Biotechnology)
|
|
|
II. Pathogenesis of Type 2 Diabetes Mellitus
- Inflammation, Mitochondria and ER Stress (English) |
(Fri. 9, 15:10~17:10, Room A)
|
|
 |
1. Obesity, Inflammation and Macrophages:
Role of chemokines in macrophage accumulation in
adipose tissue |
Anthony W. Ferrante
(Columbia University, USA)
|
|
 |
2. Role of Lipin in hepatic insulin signaling |
Seung-Hoi Koo
(Sungkyunkwan University)
|
|
 |
3. CRIF1 links genomic stresses with mitochondrial responses: The possible roles of CRIF1 in cellular senescence and insulin resistances. |
Minho Shong
(Chungnam National University)
|
|
 |
4. ER stress and β-cell dysfunction |
In-Kyu Lee
(Kyungpook National University)
|
|
| III. Clinical Update on Diabetes |
(Sat. 10, 11:10~13:10, Room A)
|
|
 |
1. Update on treatment of diabetic retinopathy |
Se Woong Kang
(Sungkyunkwan University)
|
|
 |
2. Update on non-invasive diagnosis of ischemic heart disease in diabetic patients |
Sang Il Choi
(Seoul National University)
|
|
 |
3. Update on treatment of ischemic heart disease in diabetic patients |
Chul Hwan Lee (Ulsan University)
|
|
 |
4. New therapeutic modalities for diabetes |
Jeong Taek Woo
(Kyung Hee University)
|
|
|
| Special Symposium I |
(Fri. 9, 11:00~12:00, Room B)
|
|
 |
Oxidative stress defenses and aging in C. elegans |
T. Keith Blackwell
(Harvard Medical School, USA)
|
|
|
| Special Symposium II |
(Fri. 9, 12:00~13:00, Room B)
|
|
|
 |
Role of insulin in vascular health |
Kieren J. Mather
(Indiana University, USA)
(Indiana University, USA)
|
|
|
| Committees Sessions |
|
| I. Diagnosis & Classification of DM |
(Fri. 9, 08:20~09:20, Room)
|
|
| HbA1c standardization |
|
|
| II. Treatment of DM | (Fri. 9, 08:00~09:20, Room) |
|
|
| III. TFT for Basic Statistical Study of Korean DM | (Fri. 9, 08:20~09:20, Room) |
|
|
|
| IV. Epidemiology of DM | (Fri. 9, 08:20~09:20, Room) |
| Cross-sectional study of Korean type 2 diabetic patients |
|
|
| V. Education | (Fri. 9, 11:00~13:00, Room) |
| Insulin |
|
|
| VI. Food & Nutrition | (Sat. 10, 11:10~13:10, Room) |
|
| IDM & food culture |
|
|
| VII. Training | (Sat. 10, 14:10~16:10, Room) |
|
|
| Study Group Sessions |
|
| I. Nursing | (Fri. 9, 15:10~17:10, Room)
|
|
|
|
| II. Metabolic Syndrome | (Sat. 10, 08:00~09:40, Room)
|
|
| Environmental factors and treatment targets of Metabolic Syndrome |
1. The endocannabinoid system: Treatment target of metabolic syndrome
Matthias Bluher (University of Leipzig, German) |
|
| 2. The role of CB1 on pro-inflammatory activities of macrophages |
Ki Hoon Han (Ulsan University)
|
|
3. The Influences of POPs (persistent organic pollutants) on the metabolic disease
Yhun Yong Sheen (Ewha University) |
|
|
| III. Vascular Cell | (Sat. 10, 08:00~09:40, Room) |
|
| Vascular cells research in diabetic retinopathy |
|
| GPI-anchored proteins in diabetic retinal vessels |
Yong Seek Park
(Kyung Hee University)
|
|
| New approach for retinal vascular complication in animal model |
Seo Man Son (Pusan University)
|
|
| Innovations for the treatment of diabetic retinopathy |
Hitoshi Takagi
(Kyoto University, Japan)
(Kyoto University, Japan)
|
|
|
| IV. Diabetic Neuropathy | (Sat. 10, 08:20~09:40, Room) |
| How to manage the patients with diabetic neuropathy ? |
1. Treatment of diabetic neuropathy in the pathophysiologic background
Dan Ziegler (The Heinrich Heine University, Germany) |
| 2. Impact on the quality of life of painful diabetic neuropathy in Korea |
Chong Hwa Kim (Sejong Hospital)
|
3. Diabetic Neuropathy in Korea
Dong-sun Kim (Hanyang University) |
|
|
|
| V. Exercise & DM | (Sat. 10, 08:20~09:40, Room) |
|
|
| VI. Diabetes in Elderly | (Sat. 11:10~13:10, Room) |
|
| Clinical Aspects in Elderly Diabetes |
|
|
| Satellite Symposia |
|
| Satellite Symposium I |
(Thu. 8, 17:30~18:10, Paradise)
|
|
Promising role of ARB in the treatment of metabolic syndrome & type 2 diabetesMoon Kyu Lee (Sungkyunkwan University) Sponsored by Sanofi-Aventis
|
|
|
| Satellite Symposium II |
(Thu. 8, 18:10~18:50, Paradise)
|
|
The clinical relationship between insulin resistance and glycemic control in Type 2 diabetesSteven M. Haffner (University of Texas, USA) Sponsored by G.S.K.
|
|
|
| Breakfast Symposium I |
(Fri. 9, 07:20~08:10, Room B)
|
|
| TZD efficacy and CV outcomes Seungjoon Oh (Kyung Hee University)
Sponsored by Lilly |
|
|
| Breakfast Symposium II |
(Sat. 10, 07:20~08:10, Room B)
|
|
| Current treatment guideline of diabetes |
Seok Won Park (Pochon Cha University)
Sponsored by Daewoong
Sponsored by Daewoong
|
|
|
| Sponsored Lecture I |
(Fri. 9, 14:00~15:00, Room B)
|
|
| Diabetic retinopathy: Prevention and treatment |
Jeong Hyun Park (Inje University)
Sponsored by Astra Zeneca
|
|
|
| Sponsored Lecture II |
(Fri. 9, 14:00~15:00, Room C) |
|
| 1. The burden of hypertension & exploring a rationale CCB/ARB |
Hyung Woo Lee
(Yeongnam University)
|
|
| 2. Changing the landscape of BP management |
In Ju Kim
(Pusan National University)
|
|
|
|
| Luncheon Lecture I |
(Fri. 9, 13:00~14:00, Room A) |
|
Breaking the cardiovascular disease continuum in diabetic patients
1. Sulphonylureas revisited : Focus on cardiovascular safety and side effects
Jorgen Rungby (Aarhus University Hospital, Denmark) |
|
2. Tight BP control management in diabetic patients: What ADVANCE tells us
Pavel Hamet (University of Montreal, Canada)
Sponsored by Servier |
|
|
| Luncheon Lecture II |
(Fri. 9, 13:00~14:00, Room B)
|
|
Novel long acting insulin analogues
Roger Chen (Concord Hospital, Australia)
Sponsored by Novo Nordisk |
|
|
| Luncheon Lecture III |
(Sat. 10, 13:20~14:10, Room A)
|
|
JANUVIA - The 1st physiologic glucose regulator for optimal treatment of type 2 diabetes
Russell Scott (Christchurch Hospital, New Zealand) |
|
|
| Luncheon Lecture IV |
(Sat. 10, 13:20~14:10, Room B)
|
|
The incretin therapy concept? A revolution in the treatment of type 2 diabetes Wolfgang E. Schmidt (Ruhr-University Bochum, Germany) Sponsored by Handock
|
|
